(Q40958067)

25 September 2017

1 reference

title

Bone marrow transplantation in low-grade non-Hodgkin's lymphoma (English)

1 reference

25 September 2017

Lazarus HM

1

1 reference

25 September 2017

publication date

1 April 1995

1 reference

25 September 2017

1 reference

25 September 2017

volume

17

1 reference

25 September 2017

issue

3-4

1 reference

25 September 2017

page(s)

199-210

1 reference

Treatment of non-Hodgkin's lymphoma

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

CVP—Remission—maintenance in stage I or II non-Hodgkin's lymphomasPreliminary results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Early nodal and extra-nodal non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Lymphosarcoma. A comparison of extended to conservative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Autotransplantation in lymphoma: better therapy or healthier patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Bone marrow involvement in non-Hodgkin's lymphoma: implications for staging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Induction of graft-versus-host disease after autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

Phase II trial of pentostatin in refractory lymphomas and cutaneous T-cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

2-Chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

2-Chlorodeoxyadenosine treatment of low-grade lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509056824

10.3109/10428199509056824

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference